BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Medtronic
US Army
Deloitte
Express Scripts
Argus Health
Cantor Fitzgerald
Accenture
Healthtrust
Queensland Health

Generated: January 20, 2018

DrugPatentWatch Database Preview

Cutis Health Llc Company Profile

« Back to Dashboard

What is the competitive landscape for CUTIS HEALTH LLC, and when can generic versions of CUTIS HEALTH LLC drugs launch?

CUTIS HEALTH LLC has one approved drug.

There is one US patent protecting CUTIS HEALTH LLC drugs.

Summary for Cutis Health Llc
US Patents:1
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Cutis Health Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cutis Health Llc DORAL quazepam TABLET;ORAL 018708-001 Dec 27, 1985 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cutis Health Llc DORAL quazepam TABLET;ORAL 018708-003 Feb 26, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Cutis Health Llc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cutis Health Llc DORAL quazepam TABLET;ORAL 018708-001 Dec 27, 1985 ➤ Subscribe ➤ Subscribe
Cutis Health Llc DORAL quazepam TABLET;ORAL 018708-003 Feb 26, 1987 ➤ Subscribe ➤ Subscribe
Cutis Health Llc DORAL quazepam TABLET;ORAL 018708-003 Feb 26, 1987 ➤ Subscribe ➤ Subscribe
Cutis Health Llc DORAL quazepam TABLET;ORAL 018708-001 Dec 27, 1985 ➤ Subscribe ➤ Subscribe
Cutis Health Llc DORAL quazepam TABLET;ORAL 018708-001 Dec 27, 1985 ➤ Subscribe ➤ Subscribe
Cutis Health Llc DORAL quazepam TABLET;ORAL 018708-001 Dec 27, 1985 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Baxter
Mallinckrodt
Julphar
Medtronic
Chinese Patent Office
McKinsey
Accenture
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot